{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T06:39:37Z","timestamp":1772951977773,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T00:00:00Z","timestamp":1427241600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-0905-0","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T04:01:59Z","timestamp":1427169719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Tetrandrine reverses drug resistance in isoniazid and ethambutol dual drug-resistant Mycobacterium tuberculosis clinical isolates"],"prefix":"10.1186","volume":"15","author":[{"given":"Zhe","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaijin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongkang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lanjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,25]]},"reference":[{"key":"905_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrmicro1816","volume":"6","author":"JC Sacchettini","year":"2008","unstructured":"Sacchettini JC, Rubin EJ, Freundlich JS. Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis. Nat Rev Microbiol. 2008;6:41\u201352.","journal-title":"Nat Rev Microbiol"},{"key":"905_CR2","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1128\/CMR.00061-05","volume":"19","author":"B Mathema","year":"2006","unstructured":"Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN. Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev. 2006;19:658\u201385.","journal-title":"Clin Microbiol Rev"},{"key":"905_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro1464","volume":"4","author":"LJ Piddock","year":"2006","unstructured":"Piddock LJ. Multidrug-resistance efflux pumps - not just for resistance. Nat Rev Microbiol. 2006;4:629\u201336.","journal-title":"Nat Rev Microbiol"},{"key":"905_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2011.02.022","volume":"145","author":"KN Adams","year":"2011","unstructured":"Adams KN, Takaki K, Connolly LE, Wiedenhoft H, Winglee K, Humbert O, et al. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell. 2011;145:39\u201353.","journal-title":"Cell"},{"key":"905_CR5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4103\/IJMR.2010_132_05_531","volume":"132","author":"AK Gupta","year":"2010","unstructured":"Gupta AK, Reddy VP, Lavania M, Chauhan DS, Venkatesan K, Sharma VD, et al. jefA (Rv2459), a drug efflux gene in Mycobacterium tuberculosis confers resistance to isoniazid & ethambutol. Indian J Med Res. 2010;132:176\u201388.","journal-title":"Indian J Med Res"},{"key":"905_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/mdr.2009.0054","volume":"16","author":"AK Gupta","year":"2010","unstructured":"Gupta AK, Katoch VM, Chauhan DS, Sharma R, Singh M, Venkatesan K, et al. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs. Microb Drug Resist. 2010;16:21\u20138.","journal-title":"Microb Drug Resist"},{"key":"905_CR7","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1126\/science.1083137","volume":"300","author":"EW Yu","year":"2003","unstructured":"Yu EW, McDermott G, Zgurskaya HI, Nikaido H, Koshland Jr DE. Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump. Science. 2003;300:976\u201380.","journal-title":"Science"},{"key":"905_CR8","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1093\/cvr\/27.11.1891","volume":"27","author":"MC Sutter","year":"1993","unstructured":"Sutter MC, Wang YX. Recent cardiovascular drugs from Chinese medicinal plants. Cardiovasc Res. 1993;27:1891\u2013901.","journal-title":"Cardiovasc Res"},{"key":"905_CR9","first-page":"1107","volume":"23","author":"QM Xie","year":"2002","unstructured":"Xie QM, Tang HF, Chen JQ, Bian RL. Pharmacological actions of tetrandrine in inflammatory pulmonary diseases. Acta Pharmacol Sin. 2002;23:1107\u201313.","journal-title":"Acta Pharmacol Sin"},{"key":"905_CR10","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00280-010-1397-7","volume":"67","author":"N Wei","year":"2011","unstructured":"Wei N, Sun H, Wang F, Liu G. H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein. Cancer Chemother Pharmacol. 2011;67:1017\u201325.","journal-title":"Cancer Chemother Pharmacol"},{"key":"905_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1248\/yakushi.129.623","volume":"129","author":"H Zhang","year":"2009","unstructured":"Zhang H, Gao A, Li F, Zhang G, Ho HI, Liao W. Mechanism of action of tetrandrine, a natural inhibitor of Candida albicans drug efflux pumps. Yakugaku Zasshi. 2009;129:623\u201330.","journal-title":"Yakugaku Zasshi"},{"key":"905_CR12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.2131\/jts.36.645","volume":"36","author":"YS Lee","year":"2011","unstructured":"Lee YS, Han SH, Lee SH, Kim YG, Park CB, Kang OH, et al. Synergistic effect of tetrandrine and ethidium bromide against methicillin-resistant Staphylococcus aureus (MRSA). J Toxicol Sci. 2011;36:645\u201351.","journal-title":"J Toxicol Sci"},{"key":"905_CR13","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1128\/AAC.48.7.2415-2423.2004","volume":"48","author":"XZ Li","year":"2004","unstructured":"Li XZ, Zhang L, Nikaido H. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob Agents Chemother. 2004;48:2415\u201323.","journal-title":"Antimicrob Agents Chemother"},{"key":"905_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/scbi.1997.0064","volume":"8","author":"HW van Veen","year":"1997","unstructured":"van Veen HW, Konings WN. Multidrug transporters from bacteria to man: similarities in structure and function. Semin Cancer Biol. 1997;8:183\u201391.","journal-title":"Semin Cancer Biol"},{"key":"905_CR15","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/emboj\/19.11.2503","volume":"19","author":"HW van Veen","year":"2000","unstructured":"van Veen HW, Margolles A, Muller M, Higgins CF, Konings WN. The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism. EMBO J. 2000;19:2503\u201314.","journal-title":"EMBO J"},{"key":"905_CR16","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1099\/jmm.0.46513-0","volume":"55","author":"F Nateche","year":"2006","unstructured":"Nateche F, Martin A, Baraka S, Palomino JC, Khaled S, Portaels F. Application of the resazurin microtitre assay for detection of multidrug resistance in Mycobacterium tuberculosis in Algiers. J Med Microbiol. 2006;55:857\u201360.","journal-title":"J Med Microbiol"},{"key":"905_CR17","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","volume":"366","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366:2161\u201370.","journal-title":"N Engl J Med"},{"key":"905_CR18","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3201\/eid1803.110760","volume":"18","author":"X Wang","year":"2012","unstructured":"Wang X, Fu Q, Li Z, Chen S, Liu Z, Nelson H, et al. Drug-resistant tuberculosis in Zhejiang Province, China, 1999-2008. Emerg Infect Dis. 2012;18:496\u20138.","journal-title":"Emerg Infect Dis"},{"key":"905_CR19","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1086\/651377","volume":"201","author":"S Srivastava","year":"2010","unstructured":"Srivastava S, Musuka S, Sherman C, Meek C, Leff R, Gumbo T. Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol. J Infect Dis. 2010;201:1225\u201331.","journal-title":"J Infect Dis"},{"key":"905_CR20","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/jac\/dkq186","volume":"65","author":"S Sharma","year":"2010","unstructured":"Sharma S, Kumar M, Nargotra A, Koul S, Khan IA. Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis. J Antimicrob Chemother. 2010;65:1694\u2013701.","journal-title":"J Antimicrob Chemother"},{"key":"905_CR21","first-page":"246","volume":"38","author":"AK Gupta","year":"2006","unstructured":"Gupta AK, Chauhan DS, Srivastava K, Das R, Batra S, Mittal M, et al. Estimation of efflux mediated multi-drug resistance and its correlation with expression levels of two major efflux pumps in mycobacteria. J Commun Dis. 2006;38:246\u201354.","journal-title":"J Commun Dis"},{"key":"905_CR22","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/infdis\/jiu095","volume":"210","author":"KN Adams","year":"2014","unstructured":"Adams KN, Szumowski JD, Ramakrishnan L. Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs. J Infect Dis. 2014;210:456\u201366.","journal-title":"J Infect Dis"},{"key":"905_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02933734","volume":"9","author":"GX Hu","year":"1989","unstructured":"Hu GX, Fang DC, Jiang MX. Studies on the calcium antagonistic action of tetrandrine: X VI. Hemodynamic effects of tetrandrine on conscious rats. J Tongji Med Univ. 1989;9:1\u20134.","journal-title":"J Tongji Med Univ"},{"key":"905_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1128\/MMBR.69.2.326-356.2005","volume":"69","author":"JL Ramos","year":"2005","unstructured":"Ramos JL, Martinez-Bueno M, Molina-Henares AJ, Teran W, Watanabe K, Zhang X, et al. The TetR family of transcriptional repressors. Microbiol Mol Biol Rev. 2005;69:326\u201356.","journal-title":"Microbiol Mol Biol Rev"},{"key":"905_CR25","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1128\/AAC.46.9.2804-2810.2002","volume":"46","author":"M Viveiros","year":"2002","unstructured":"Viveiros M, Portugal I, Bettencourt R, Victor TC, Jordaan AM, Leandro C, et al. Isoniazid-induced transient high-level resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2002;46:2804\u201310.","journal-title":"Antimicrob Agents Chemother"},{"key":"905_CR26","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.2174\/15672050113109990203","volume":"20","author":"V Bernardes-Genisson","year":"2013","unstructured":"Bernardes-Genisson V, Deraeve C, Chollet A, Bernadou J, Pratviel G. Isoniazid: an update on the multiple mechanisms for a singular action. Curr Med Chem. 2013;20:4370\u201385.","journal-title":"Curr Med Chem"},{"key":"905_CR27","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1128\/AAC.06003-11","volume":"56","author":"M Balganesh","year":"2012","unstructured":"Balganesh M, Dinesh N, Sharma S, Kuruppath S, Nair AV, Sharma U. Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidates. Antimicrob Agents Chemother. 2012;56:2643\u201351.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-0905-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0905-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0905-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0905-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T13:26:29Z","timestamp":1747833989000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-0905-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,25]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["905"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-0905-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,25]]},"assertion":[{"value":"25 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"153"}}